Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Correction of Iron Deficiency in Hospitalized Heart Failure Patients Does Not Improve Patient Outcomes

Ronak Mistry, DO, Andrew Kohut, MD MPH, Patricia Locantore-Ford, MD

Blood (2019) 134 (Supplement_1): 4812.

https://doi.org/10.1182/blood-2019-123568

Published: 2019

Journal Articles

Mapping Comorbidity in CLL: Impact on Prognostic Factors, Treatment Patterns and Causes of Death

Emelie Curovic Rotbain, MD, Carsten Utoft Niemann, MD PhD Ass. Prof, Klaus Rostgaard, MSc., Caspar Da Cunha-Bang, MD PhD, Henrik Hjalgrim, MD Dr.MD, Henrik Frederiksen, MD Prof

Blood (2019) 134 (Supplement_1): 4285.

https://doi.org/10.1182/blood-2019-122673

Published: 2019

Journal Articles

Sex Differences in Risk Factors, Clinical Presentation, Treatment and Outcomes of Patients Presenting with Acute Pulmonary Embolism

Rachel P Rosovsky, MDMPH, Islam Y Elgendy, MD, Suzanne C Cannegieter, MD PhD, Menno V Huisman, MD PhD, David Jimenez, MD PhD, Jorge del Toro, MD, Vladimir Rosa, MD PhD, Carmen Fernández-Capitán, MD PhD, Alessandra Bura-Riviere, MD PhD, Manuel Monreal, MD PhD

Blood (2019) 134 (Supplement_1): 2429.

https://doi.org/10.1182/blood-2019-131090

Published: 2019

Journal Articles

NOAC Therapy Is Also Effective and Safe in Patients Older Than 80 Years — Results of the Prospective Dresden NOAC Registry (NCT01588119)

Jan Beyer-Westendorf, MD, Luise Tittl, Christiane Naue, MD, Sandra Marten, MD

Blood (2018) 132 (Supplement 1): 422.

https://doi.org/10.1182/blood-2018-99-118081

Published: 2018

Journal Articles

Iron Supplementation: What's New?

Iain C. Macdougall, MD

Blood (2017) 130 (Supplement 1): SCI-43.

https://doi.org/10.1182/blood.V130.Suppl_1.SCI-43.SCI-43

Published: 2017

Journal Articles

Prevention of Morbidity in Sickle Cell Disease Phase II (Improvement of Pain and Quality of Life in Children with Sickle Cell Disease with Auto-adjusting Continuous Positive Airways Pressure: Phase II) (POMS 2b pediatric cohort)

Baba Inusa, MD MRCP, Jo Howard, MBBCh, Subarna Chakravorty, MBBS, PhD FRCPath, MRCP, Maria Pelidis, MD, Swee Lay Thein, DSc,FRCP,FRCPath,MBBS,MRCPath,MRCP, Fenella J Kirkham, MD

Blood (2017) 130 (Supplement 1): 3537.

https://doi.org/10.1182/blood.V130.Suppl_1.3537.3537

Published: 2017

Journal Articles

Cardiorenal Syndrome in Thalassemia Patients

Sorasak Makmettakul, MD, Adisak Tantiworawit, MD, Suree Lekawanvijit, MD, Arintaya Phrommintikul, MD, Thanawat Rattanathammethee, MD, Sasinee Hantrakool, MD, Chatree Chai-Adisaksopha, MD, Ekarat Rattarittamrong, MD, Lalita Norasetthada, MD

Blood (2017) 130 (Supplement 1): 3507.

https://doi.org/10.1182/blood.V130.Suppl_1.3507.3507

Published: 2017

Journal Articles

Prevention of Morbidity in Sickle Cell Disease Phase II (Improvement of Cognition in children with Sickle Cell Disease with Auto-adjusting Continuous Positive Airways Pressure: Phase II) (POMS 2b paediatric cohort)

April E Slee, Jamie M Kawadler, PhD, Melanie Koelbel, MSc, Hanne Stotesbury, MSc, David C Rees, MD, Maria Pelidis, MD, Jo Howard, MBBCh, Swee Lay Thein, DSc,FRCP,FRCPath,MBBS,MRCPath,MRCP, Simon Skene, PhD, Sahota Sati, BSc, Carol Nwosu, BSc, Maureen Gwam, BSc, Dawn Saunders, MD, Johanna C Gavlak, PhD, Gupta Atul, MD, Simrat Sarkaria, Christina Liossi, PhD, Fenella J Kirkham, MD, Baba Inusa, MD MRCP

Blood (2017) 130 (Supplement 1): 3556.

https://doi.org/10.1182/blood.V130.Suppl_1.3556.3556

Published: 2017

Journal Articles

Health-Related Quality of Life in Lenalidomide and Bortezomib Treated Patients with Relapsed/Refractory Multiple Myeloma

Charalampia Kyriakou, MD PhD, Philip Murphy, MD, Maria Teresa Petrucci, MD, Pamela Bacon, Philip Lewis, Hélène Gilet, MSc, Benoit Arnould, PhD, Isabelle Vande Broek, MD PhD, Xavier Leleu, MD

Blood (2015) 126 (23): 2085.

https://doi.org/10.1182/blood.V126.23.2085.2085

Published: 2015

Journal Articles

Drug Persistence with Rivaroxaban Therapy in Atrial Fibrillation Patients Results from the Dresden NOAC registry

Jan Beyer-Westendorf, MD, Kati Förster, Franziska Ebertz, Vera Gelbricht, Franziska Michalski, Luise Tittl, Norbert Weiss, Prof.

Blood (2014) 124 (21): 4264.

https://doi.org/10.1182/blood.V124.21.4264.4264

Published: 2014

Journal Articles

Centrally Adjudicated Cause of Death during Noac Treatment – Results of the Prospective Dresden Noac Registry (NCT01588119)

Franziska Michalski, Sebastian Werth, MD, Christina Köhler, MD, Luise Tittl, Katharina Daschkow, Jan Beyer-Westendorf, MD

Blood (2014) 124 (21): 2876.

https://doi.org/10.1182/blood.V124.21.2876.2876

Published: 2014

Journal Articles

Thromboprophylaxis use in medical inpatients and the impact of electronic risk assessment tool

Nikhil Mukhi, MD, Gurinder Sidhu, MD, Christopher Nabors, Chaitanya Iragavarapu

Blood (2014) 124 (21): 3511.

https://doi.org/10.1182/blood.V124.21.3511.3511

Published: 2014

Journal Articles

Characteristics of Atrial Fibrillation Patients Not Switched from Vka to Noac and Persistence on Vka – a Subgroup Analysis of the Prospective Dresden Noac Registry (NCT01588119)

Jan Beyer-Westendorf, MD, Franziska Michalski, Sebastian Werth, MD, Luise Tittl, Christina Köhler, MD, Norbert Weiss, Prof.

Blood (2014) 124 (21): 1538.

https://doi.org/10.1182/blood.V124.21.1538.1538

Published: 2014

Journal Articles

Inflammatory Cytokines Are Upregulated in Patients with Implanted Ventricular Assist Devices

Walter Jeske, PhD, Daneyal Syed, BS, Vicki Escalante, BS, Erin Coglianese, Jeffrey Schwartz, MD, Jeanine M. Walenga, PhD

Blood (2014) 124 (21): 5049.

https://doi.org/10.1182/blood.V124.21.5049.5049

Published: 2014

Journal Articles

Incidence and Predictors Of Venous Thromboembolism Among Lymphoma Patients In Denmark: A Nationwide Population-Based Cohort Study

Jennifer L Lund, PhD, Lene Sofie Granfeldt Ostgard, MD, Paolo Prandoni, MD, PhD, Henrik Toft Sorensen, Peter de Nully Brown, MD

Blood (2013) 122 (21): 934.

https://doi.org/10.1182/blood.V122.21.934.934

Published: 2013

Journal Articles

Metabolomic Profiles Reveal Sphingosine-1-Phosphate As a Novel Allosteric Modulator of Hemoglobin-Oxygen Affinity and a Key Contributor to Pathophysiology of Sickle Cell Disease

Yujin Zhang, Vladimir Berka, Wei Wang, Weiru Zhang, Chen Ning, Kaiqi Sun, Danny C Alexander, Michael Milburn, Mostafa Ahmed, Modupe Idowu, MD, Rodney E. Kellems, Jun Zhang, MD, Martin Safo, Ah-lim Tsai, Harinder S. Juneja, Yang Xia

Blood (2011) 118 (21): LBA-3.

https://doi.org/10.1182/blood.V118.21.LBA-3.LBA-3

Published: 2011

Journal Articles

NT-Probnp as a Marker of Cardiopulmonary Compromise and Exercise Limitation In Adults with Sickle Cell Anemia In the Walk-PHaSST Study

Blood (2010) 116 (21): 1639.

https://doi.org/10.1182/blood.V116.21.1639.1639

Published: 2010

Journal Articles

Is Liposome Encapsulated Doxorubicin Able to Reduce the Cardiotoxicity of Doxorubicin In the Treatment of DLBCL? A Randomised Study by the Austrian Working Party of Medical Oncology (AGMT-study NHL-14)

Michael Fridrik, MD, Andreas L Petzer, MD, Felix Keil, MD, Wolfgang Willenbacher, MD, Ulrich Jäger, MD, Alois Lang, MD, Johannes Andel, MD, Otto Krieger, MD, Wilhelm Oberaigner, Richard Greil, MD

Blood (2010) 116 (21): 1766.

https://doi.org/10.1182/blood.V116.21.1766.1766

Published: 2010

Journal Articles

The Ultra-Low-Molecular-Weight Heparin Semuloparin for Prevention of Venous Thromboembolism In Patients Undergoing Major Abdominal Surgery

Ajay K. Kakkar, MBBS, PhD, Giancarlo Agnelli, William D. Fisher, MD, Daniel George, Patrick Mouret, Michael R. Lassen, MD, Patrick Mismetti, Judith Murphy, Alexander G.G. Turpie

Blood (2010) 116 (21): 188.

https://doi.org/10.1182/blood.V116.21.188.188

Published: 2010

Journal Articles

Appropriate VTE Prophylaxis Is Associated with Lower Direct Medical Costs among Medical and Surgical Patients in the United States.

Alpesh Amin, MD, MBA, FACP, Mohamed Hussein, Ms.C.S., M.S.P.H, Ph.D., David Battleman, MD, Jay Lin, PhD, MBA, Steve Stemkowski, MHA, Geno J Merli, MD

Blood (2008) 112 (11): 1287.

https://doi.org/10.1182/blood.V112.11.1287.1287

Published: 2008

NARROW

Correction of Iron Deficiency in Hospitalized Heart Failure Patients Does Not Improve Patient Outcomes

Mapping Comorbidity in CLL: Impact on Prognostic Factors, Treatment Patterns and Causes of Death

Sex Differences in Risk Factors, Clinical Presentation, Treatment and Outcomes of Patients Presenting with Acute Pulmonary Embolism

NOAC Therapy Is Also Effective and Safe in Patients Older Than 80 Years — Results of the Prospective Dresden NOAC Registry (NCT01588119)

Iron Supplementation: What's New?

Prevention of Morbidity in Sickle Cell Disease Phase II (Improvement of Pain and Quality of Life in Children with Sickle Cell Disease with Auto-adjusting Continuous Positive Airways Pressure: Phase II) (POMS 2b pediatric cohort)

Cardiorenal Syndrome in Thalassemia Patients

Prevention of Morbidity in Sickle Cell Disease Phase II (Improvement of Cognition in children with Sickle Cell Disease with Auto-adjusting Continuous Positive Airways Pressure: Phase II) (POMS 2b paediatric cohort)

Health-Related Quality of Life in Lenalidomide and Bortezomib Treated Patients with Relapsed/Refractory Multiple Myeloma

Drug Persistence with Rivaroxaban Therapy in Atrial Fibrillation Patients Results from the Dresden NOAC registry

Centrally Adjudicated Cause of Death during Noac Treatment – Results of the Prospective Dresden Noac Registry (NCT01588119)

Thromboprophylaxis use in medical inpatients and the impact of electronic risk assessment tool

Characteristics of Atrial Fibrillation Patients Not Switched from Vka to Noac and Persistence on Vka – a Subgroup Analysis of the Prospective Dresden Noac Registry (NCT01588119)

Inflammatory Cytokines Are Upregulated in Patients with Implanted Ventricular Assist Devices

Incidence and Predictors Of Venous Thromboembolism Among Lymphoma Patients In Denmark: A Nationwide Population-Based Cohort Study

Metabolomic Profiles Reveal Sphingosine-1-Phosphate As a Novel Allosteric Modulator of Hemoglobin-Oxygen Affinity and a Key Contributor to Pathophysiology of Sickle Cell Disease

NT-Probnp as a Marker of Cardiopulmonary Compromise and Exercise Limitation In Adults with Sickle Cell Anemia In the Walk-PHaSST Study

Is Liposome Encapsulated Doxorubicin Able to Reduce the Cardiotoxicity of Doxorubicin In the Treatment of DLBCL? A Randomised Study by the Austrian Working Party of Medical Oncology (AGMT-study NHL-14)

The Ultra-Low-Molecular-Weight Heparin Semuloparin for Prevention of Venous Thromboembolism In Patients Undergoing Major Abdominal Surgery

Appropriate VTE Prophylaxis Is Associated with Lower Direct Medical Costs among Medical and Surgical Patients in the United States.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only